BioAge Labs (BIOA) Total Non-Current Liabilities (2023 - 2026)

BioAge Labs has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $21.3 million for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities fell 21.72% year-over-year to $21.3 million; the TTM figure through Jun 2026 stood at $21.3 million (down 21.72% YoY), while the FY2025 annual figure was $22.5 million, down 35.72% from the prior year.
• Total Non-Current Liabilities came in at $21.3 million for Q2 2026 at BioAge Labs, up from $18.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $66.4 million in Q4 2023 to a low of $18.1 million in Q1 2026.
• Average Total Non-Current Liabilities over 4 years is $30.2 million, with a median of $27.3 million recorded in 2025.
• Year-over-year, Total Non-Current Liabilities tumbled 47.34% in 2024 and climbed 19.36% in 2025.
• Over 4 years, Total Non-Current Liabilities stood at $66.4 million in 2023, then plunged by 47.34% to $35.0 million in 2024, then slumped by 35.72% to $22.5 million in 2025, then retreated by 5.03% to $21.3 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $21.3 million in Q2 2026, $18.1 million in Q1 2026, and $22.5 million in Q4 2025.